Public Hearing on Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools

Food and Drug Administration
National Transportation Safety Board Conference Center
429 L'Enfant Plaza, SW., Washington DC, 20594
November 12 and 13, 2009
8:00 a.m. to 5:00 p.m. each day
http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm184250.htm

The Food and Drug Administration (FDA) will hold a public hearing to provide an opportunity for broad public participation and comment on promotion of FDA-regulated medical products (including prescription drugs for humans and animals, prescription biologics, and medical devices) using the Internet and social media tools. FDA is seeking participation in the public hearing and written comments from all interested parties, including, but not limited to, consumers, patients, caregivers, health care professionals, patient groups, Internet vendors, advertising agencies, and the regulated industry. This meeting and written comments are intended to help guide FDA in making policy decisions on the promotion of human and animal prescription drugs and biologics and medical devices using the Internet and social media tools. FDA is seeking input on a number of specific questions but is interested in any other pertinent information participants in the hearing would like to share.